|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
21 July 2016 |
|
Main ID: |
NCT02824419 |
|
Date of registration:
|
27/05/2016 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Imaging of Active Granulomas With [18F]FDG and Selected Inflammatory PET Tracers in Pulmonary Sarcoidosis
|
|
Scientific title:
|
Imaging of Active Granulomas With [18F]FDG and Selected Inflammatory PET Tracers in Pulmonary Sarcoidosis |
|
Date of first enrolment:
|
May 2016 |
|
Target sample size:
|
10 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT02824419 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
|
|
Phase:
|
Phase 2/Phase 3
|
|
|
Countries of recruitment
|
|
Finland
| | | | | | | |
|
Contacts
|
|
Name:
|
Riikka Lautamaki, MD, PhD |
|
Address:
|
|
|
Telephone:
|
+358 2 313 0000 |
|
Email:
|
riikka.lautamaki@tyks.fi |
|
Affiliation:
|
|
|
|
Name:
|
Juhani Knuuti, MD, PhD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Turku PET Centre, Turku University Hospital, Turku, Finland |
|
|
Name:
|
Riikka Lautamaki, MD, PhD |
|
Address:
|
|
|
Telephone:
|
+3582 3130000 |
|
Email:
|
riikka.lautamaki@tyks.fi |
|
Affiliation:
|
|
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patient with sarcoidosis
Exclusion Criteria:
- any malignant disease
- any significant other inflammatory or infectious disease affecting lungs
- pregnancy
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Pulmonary Sarcoidosis
|
|
Intervention(s)
|
|
Drug: Methionine
|
|
Drug: DOTANOC
|
|
Primary Outcome(s)
|
|
The detection of sarcoidotic lesion with C11-methionine or 68Ga-DOTANOC.
[Time Frame: baseline]
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|